Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,462 total articles
Eli Lilly remains a growth engine thanks to GLP-1 momentum and new oncology wins, yet valuation and mixed technicals argue for a disciplined, mid-term trade. Buy on a measured entry near $1,160 with a stop under $1,110 and a target into the $1,250 area ahead of/after Q3 results.
AvePoint, a SaaS data governance specialist, stands to benefit from rising enterprise demand for agent-level AI governance. Recent research showing widespread visibility gaps plus reasonable valuation metrics and improving technicals create an actionable long trade: enter at $14.60, stop at $12.00, target $20.00 over a 180-trading-day horizon.
Intuit's shares have been punished on concerns around AI disruption, slowing customer adds and a shift toward customer-acquisition spending. That creates a tactical entry: buy near $290 for a mid-term swing to $350 over ~45 trading days, using a $260 stop. The company's $77B market cap, $8.66B in free cash flow and 30%+ growth in strategic 'Big Bet…
Rambus sits squarely in the path of AI-driven memory upgrades thanks to its high-speed memory interface IP and security offerings. The fundamentals show healthy cash generation and strong returns, yet the stock trades at a high multiple. This trade idea buys into the AI theme while protecting against execution risk with a clear stop.
Micron's fiscal momentum and capacity-backed exposure to AI data center demand argue that the recent pullback is a buying opportunity, not the end of the rally. Market-cap scale, strong free cash flow and healthy balance-sheet metrics support a tactical long. Trade with a clear stop and time-box the idea to a mid-term horizon.
Zscaler (ZS) rallied back toward $213 after a strong multi-week run, but market-capary enthusiasm and stretched multiples leave the stock vulnerable. With a market cap near $34.6B, EV/S north of 10x and negative trailing EPS, this trade targets a mid-term pullback to $170 over roughly 45 trading days using a disciplined stop at $235.
We added 1,000 shares of Enbridge (ENB) to the model portfolio at $46.88. The stock offers a 6.0% yield, stable fee-driven cash flow, and a valuation that still looks reasonable relative to cash generation. Our trade plan: entry $46.88, stop $44.00, target $54.00 over a long-term horizon (180 trading days).
Petrobras (PBR) looks set to trade on a near-term political catalyst after an election-driven pop and fresh exploration/production catalysts. Fundamentals are cheap by headline multiples and the company sports a healthy dividend yield, but the stock is technically extended and election risk creates a binary outcome. This trade plan targets a discip…
Baker Hughes (BKR) combines improving technical action with a steady stream of large equipment and service orders across LNG, gas compression and offshore production. The company's cash flow, manageable leverage and diversified Energy Technology footprint make a tactical long trade attractive into 10/27/2026 earnings and across the next 180 trading…
Vaxcyte (PCVX) is a Strong Buy from our desk into a run of pivotal readouts for VAX-31 and related programs. The shares have pulled back to $66.62 after a sharp run-up; positive Phase 3 / IPD efficacy data in the coming months would likely re-rate this name materially given its 31-valent coverage and recent validation in The Lancet. We lay out an a…
Clarivate (CLVT) just showed that organic revenue growth is back, guided to free cash flow growth, and is exploring asset sales to simplify the business. The stock is deeply discounted on standard cash-flow multiples, but the story hinges on execution — specifically converting improving revenue into sustainable free cash flow and reducing leverage.…
AT&T is posting durable subscriber growth in fiber and fixed wireless while trading at single-digit multiples. On a market-cap basis the company generates roughly $13.3B in free cash flow, implying a high-single-digit FCF yield and a 4.6% dividend yield. We like a tactical long into the next earnings/catalyst window with defined risk controls.
<p>Discovery Mining looks priced for stagnation today but management's development program and a near-term construction pipeline create a plausible path to triple gold output over the next 12-24 months. This trade idea outlines a risk-managed long-term entry that targets the market re-rating if execution and resource upgrades proceed as guided.</p>
Jefferson Capital (JCAP) is a small-cap specialty servicer trading at a low multiple with improving cash generation and meaningful portfolio additions. The thesis: rising recoveries from recent portfolio purchases and a $1.0B revolver reduce execution risk and support free cash flow. Enter a long with tight risk controls — target the high $20s if c…
Genmab's epcoritamab plus R-CHOP Phase 3 victory in newly diagnosed DLBCL is a step-change catalyst that justifies a tactical long. The stock offers asymmetric upside given a $22.6B market cap, supportive technicals, and still-clear commercialization milestones. Trade plan: enter on a measured pullback, stop below the $34.50 support band, and targe…
Energy Transfer (ET) is trading near the low end of its recent range after a modest pullback. With a market cap around $71B, strong free cash flow ($5.22B last reported), a 6.5% distribution yield, and a freshly announced $2.6B Vaquero acquisition that is immediately accretive, we view the current weakness as a buying opportunity. Our proprietary v…
Palantir is trading at $192.47 with a $462.5B market cap and stretched multiples, but fundamentals - sticky government contracts, accelerating commercial wins, improving cash flow - and technical momentum make a calculated long trade appealing. This idea lays out entry, stop, targets, catalysts and the risks that could derail the thesis.
Tradeweb (TW) remains a compelling way to play secular migration of institutional trading to electronic venues. The company combines high margins, strong free cash flow and recurring client relationships. This trade idea outlines a long entry at $105.00, a stop at $95.00 and a target of $125.00 over a long-term (180 trading days) horizon, with expl…
Micron is the memory bellwether: rising AI/data-center demand plus constrained industry capacity make the current pullback a buying opportunity. Balance-sheet strength, $26.2B in free cash flow and double-digit operating leverage support a path to materially higher earnings and a $1,400 stock target over the next 180 trading days if market conditio…
Nvidia's GPUs sit at the choke point of AI infrastructure. With balance-sheet strength, outsized free cash flow, and bullish technicals, NVDA is a high-conviction long for investors who believe the industry faces a persistent capital bottleneck. This trade lays out an entry at current levels, a protective stop, and a 180-trading-day target that ref…
Aurora's Driver is moving from pilots to revenue-generating routes and marquee partnerships. With a market cap near $11.5B and a cash cushion, the stock is trading below its 52-week high but above cycle lows. This trade idea buys into improving commercialization while protecting capital for a bumpy operational scaling phase.
Central Puerto (CEPU) trades at just under book with a 7.2% yield and a sub-6x PE. We see a mid-term swing opportunity to buy weakness into fundamental and macro catalysts while sizing risk around Argentina macro and operational variability.
AST SpaceMobile is showing renewed momentum: price clearing the 50-day with heavy volume, meaningful short interest and accelerating revenue estimates. The stock is expensive on traditional metrics, but this trade idea targets a 50%+ upside over a multi-month horizon while limiting downside with a disciplined stop.
Astronics (ATRO) reported a strong quarter with record Aerospace backlog, accelerating seat-motion and military bookings, and improving Test Systems book-to-bill. The stock has pulled back from recent highs, creating a tactical buying opportunity. We like a mid-term swing trade into $85 driven by backlog conversion, commercial fleet retrofit demand…
ChipMOS (IMOS) is trading near the top of its 52-week range after a strong run. The company's testing and assembly footprint, exposure to advanced packaging and a recurring dividend create an asymmetric risk/return profile for long-horizon traders. This trade idea outlines an entry at $78.00, a stop at $62.00 and a target of $115.00 over a 180 trad…
